According to Novavax's latest financial reports the company's current earnings are A$0.68 Billion. , an increase over its 2023 earnings that were of -A$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -A$0.25 Billion | -70.39% |
2023 | -A$0.83 Billion | -16.59% |
2022 | -A$1 Billion | -62.58% |
2021 | -A$2.65 Billion | 320.54% |
2020 | -A$0.63 Billion | 234.22% |
2019 | -A$0.19 Billion | -30.17% |
2018 | -A$0.27 Billion | 1.69% |
2017 | -A$0.27 Billion | -36.44% |
2016 | -A$0.42 Billion | 70.4% |
2015 | -A$0.25 Billion | 89.27% |
2014 | -A$0.13 Billion | 59.83% |
2013 | -A$80.97 Million | 81.9% |
2012 | -A$44.51 Million | 50.33% |
2011 | -A$29.61 Million | |
2009 | -A$58.43 Million | 8.8% |
2008 | -A$53.71 Million | 18.01% |
2007 | -A$45.51 Million | 18.33% |
2006 | -A$38.47 Million | 168.31% |
2005 | -A$14.34 Million | -62.51% |
2004 | -A$38.24 Million | 52.4% |
2003 | -A$25.1 Million | -28.21% |
2002 | -A$34.95 Million | |
2000 | -A$19.92 Million | 177% |
1999 | -A$7.19 Million | -11.54% |
1998 | -A$8.13 Million | 10.64% |
1997 | -A$7.35 Million | -9.62% |
1996 | -A$8.13 Million |